Global Angiotensin Receptor Blockers (ARBs) Market Poised to Expand a Global Angiotensin Receptor Blockers

Global Angiotensin Receptor Blockers (ARBs) Market Poised to Expand at a
Robust Pace Over 2019 – 2025
The study delivers in-depth insights on the Global Angiotensin Receptor Blockers (ARBs)
Market in its upcoming report titled, “Global Angiotensin Receptor Blockers (ARBs) Market
Poised to expand at a Robust Pace Over 2019-2025”. This research report classifies the global
market based on top manufactures, region, type and end user. The report further offers
analytical data of trading aspects such as local consumption, global consumption, import, and
exports. It focuses on the major players in the worldwide Angiotensin Receptor Blockers (ARBs)
market in terms of the competition analysis, value, sales volumes, SWOT analysis, and detailed
company profiles.
Top manufacturers for the market (share, demand, growth, production supply analysis): Pfizer,
Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly and Company, Sanofi SA, Bristol-
Myers Squibb, Bayer, GSK, Teva Pharmaceutical.
Request for Sample Report @
https://www.qandqmarketresearch.com/report-sample/648800
About Angiotensin Receptor Blockers (ARBs) Market:
Angiotensin II receptor blockers (ARBs), also known as angiotensin II receptor antagonists, AT1
receptor antagonists or sartans, are a group of pharmaceuticals that modulate the rennin
angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure),
diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block
the activation of AT1receptors, preventing the binding of angiotensin II.The global Angiotensin
Receptor Blockers (ARBs) market was xx million US$ in 2018 and is expected to xx million US$
by the end of 2025, growing at a CAGR of xx% between 2019 and 2025.
Market Segment by Product Type
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
Market Segment by Application
Hypertension